The Effect of Adding Selenium to the Treatment Regimen on Outcomes of Patients with COVID-19: A Randomized Clinical Trial

Read full text Summarise with VIRAT
Authors: Tahoura Afshari Saleh, Seyed Taha Hoseini, Davood Soroosh, Afsaneh Kaffash, Lahya Afshari Saleh
Cited by: 0
References: 27

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Some studies indicate that selenium is essential in the host’s response to viral infections. This study aimed to investigate the effect of selenium administration on clinical outcomes in hospitalized patients with COVID-19. Methods: This clinical trial was conducted in Sabzevar in 2020–2021 (registration code: IRCT20160706028815N5) on hospitalized patients with COVID-19. Demographic data, clinical symptoms, and CT scan findings were recorded. The participants were randomly divided into two groups. The control group received standard care based on the latest national treatment protocols for COVID-19. The intervention group received selenium in addition to routine treatment. Clinical outcomes were compared between the two groups using SPSS statistics software. A significance level of 0.05 was considered. Results: Fifty-four patients were randomly assigned to the intervention (n=29) and control (n=25) groups. Twenty-nine men (53.7%) and 25 women (46.3%) were included in the study. The mean and SD of age and body mass index of participants were 58.3±16.8 and 25.8±3.3, respectively. The groups were similar in terms of gender, addiction, smoking, commodities, symptoms, amount of pulmonary parenchyma involvement in the lung CT scan, age, and body mass index. The duration of admission was significantly shorter in the intervention group (P=0.03). There was no significant difference in terms of ICU admission, mechanical ventilation, and 30- and 90-day mortality rates. Conclusion: The present study showed that the administration of selenium can reduce the duration of the disease. Other clinical outcomes did not show significant differences between the two groups.

Fields of Study & Subjects

COVID-19 Clinical Research Studies Selenium in Biological Systems Trace Elements in Health

Publication details

Journal / source
Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān.
Volume
33
Pages
3978–3978
Publication date
6 January 2026
Language
EN